Microbot Medical Inc. MBOT
1.28
(0.03)
(2.29%)
as of 25 Sep
- Market cap
- $88.0M
- P/E
- 0.0×
Follow MBOT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (32.91%) | (27.58%) | (32.42%) | (31.87%) |
+8 more TTM periods Free account |
|
| (30.68%) | (26.09%) | (30.01%) | (30.06%) | ||
ROIC |
(850.51%) | (506.63%) | 0.00% | 0.00% | |
Return on Tangible Assets |
(23.82%) | (19.38%) | (17.18%) | (16.77%) | |
Average Days of Receivables |
155.51 | 198.47 | — | — | |
Free Cash Flow per Share |
(0.27) | (0.23) | (0.29) | (0.23) | |
Free Cash Flow |
(17.93) | (15.38) | (13.11) | (11.02) | |
Capital Expenditures |
(0.29) | (0.15) | (0.06) | (0.04) | |
Piotroski F-Score |
4.00 | 4.00 | — | — | |
| Other line items | |||||
Cash ROIC |
(12.92%) | (10.33%) | (8.32%) | (6.93%) | |
Accounts Receivable Turnover |
2.36 | 0.87 | — | — | |
Accounts Payable Turnover |
1.50 | 0.27 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | — | — | |
Average Days of Payables |
307.76 | 2,276.01 | 0.00 | 0.00 | |
Days of Inventory on Hand |
1,027.16 | 4,734.51 | 0.00 | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1,420.24% | 3,167.79% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2,904.62% | 5,140.86% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
295.09% | 529.78% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.08 | 1.07 | 0.99 | 0.84 | |
Depreciation/Fixed assets |
0.15 | 0.23 | 0.51 | 0.81 | |
Capex/Depreciation |
(6.13) | (3.52) | (1.28) | (0.67) | |
Revenue per Share |
0.01 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.26) | (0.23) | (0.28) | (0.23) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.70 | 0.80 | 0.00 | 0.00 | |
Net Profit Margin |
(3,955.22%) | (7,359.92%) | 0.00% | 0.00% |
Columns are period end dates